transitioning from tirzepatide to retatrutide vs. Retatrutide: Key Differences Explained Here's a guide on switching

The National Academies of Sciences, Engineering, and Medicine (NASEM) released a concurrent report that argues that if you look at alcohol in the absence of obesity, the risk of breast cancer is a lot lower than we thought

Additionally, breast cancer survivors who used GLP1-RAs for diabetes or obesity had a significantly lower risk of their cancer returning over 10 years following their initial treatment

Like stress, certain illnesses, and iron deficiency, these changes are usually temporary

Significant weight loss from tirzepatide may reduce levothyroxine requirements in some patients, necessitating TSH monitoring at baseline, after substantial weight loss, and every 6-12 months once stable

However, this theoretical benefit is undermined if the pharmacy is simultaneously recommending unsupported storage conditions like freezing